Transvaginal mesh was developed to repair pelvic damage to women who have suffered from stress urinary incontinence or pelvic organ prolapse. This mesh can be inserted with a minimally invasive procedure and is meant to patch or strengthen weakened or destroyed tissue.
However, thousands of women have experienced problems with the mesh, ranging from pain to organ damage. These injuries have included:
- Bleeding from the mesh site
- Damage to nearby organs
- Erosion of the mesh
- Pain, including pain during intercourse
- Urinary tract problems, including continued or increased incontinence
Many manufacturers of the product have faced, or are currently facing, legal action for the damages sustained by patients. One of the most prominent companies facing these issues is the Avaulta Anterior and Posterior Biosynthetic Support System made by C. R. Bard Inc., with about 9,000 Bard transvaginal mesh lawsuits currently pending in consolidated federal multidistrict litigation.
The first company to release the mesh, Boston Scientific, issued a recall on its devices only a few years after its release in the 1990s. However, mass studies and action on the devices as only come to a head in the last few years. In 2012, the FDA ordered 33 makers of transvaginal mesh products to conduct testing on patient outcomes and report all complications stemming from the use of their products.
In July 2014, the FDA denied a ban on U.S. sales of transvaginal mesh products, despite a petition filed by Public Citizen’s Health Research Group asking for discontinued use and ban on the products. Currently, Derek Potts is serving in a leadership role in several multi-district litigation efforts to hold manufacturers responsible and protect women from the dangers of transvaginal mesh.
The Potts Law Firm is actively participating in many MDLs and claims regarding transvaginal mesh. If you or a loved one has been harmed as a result of transvaginal mesh from any manufacturer, contact The Potts Law Firm today to arrange your free consultation.